130 related articles for article (PubMed ID: 32346580)
1. Dataset of
Garcia SAB; Araújo M; Freitas R
Data Brief; 2020 Jun; 30():105572. PubMed ID: 32346580
[TBL] [Abstract][Full Text] [Related]
2. Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis.
Rondón-Lagos M; Verdun Di Cantogno L; Marchiò C; Rangel N; Payan-Gomez C; Gugliotta P; Botta C; Bussolati G; Ramírez-Clavijo SR; Pasini B; Sapino A
Mol Cytogenet; 2014 Jan; 7(1):8. PubMed ID: 24456987
[TBL] [Abstract][Full Text] [Related]
3. HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype.
de Bessa Garcia SA; Araújo M; Pereira T; Freitas R
Biomedicines; 2021 May; 9(5):. PubMed ID: 34063128
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.
Li X; Chen S; Zhu Y; Fei J; Song L; Sun G; Niu W; Guo L; Wang J
J Gastrointest Oncol; 2021 Oct; 12(5):2132-2149. PubMed ID: 34790380
[TBL] [Abstract][Full Text] [Related]
5. In vivo mutagenesis of the Hoxb8 hexapeptide domain leads to dominant homeotic transformations that mimic the loss-of-function mutations in genes of the Hoxb cluster.
Medina-Martínez O; Ramírez-Solis R
Dev Biol; 2003 Dec; 264(1):77-90. PubMed ID: 14623233
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.
De Iuliis F; Salerno G; Giuffrida A; Milana B; Taglieri L; Rubinacci G; Giantulli S; Terella F; Silvestri I; Scarpa S
Tumour Biol; 2016 Feb; 37(2):2603-11. PubMed ID: 26392111
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer recurrence according to molecular subtype.
Shim HJ; Kim SH; Kang BJ; Choi BG; Kim HS; Cha ES; Song BJ
Asian Pac J Cancer Prev; 2014; 15(14):5539-44. PubMed ID: 25081661
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
10. [Influence of human cytomegalovirus infection on the expression of HOXB5, HOXB6, HOXB7, and HOXB8 genes in gliomaous cells].
Wu GJ; Chen LY; Dai G
Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):409-11. PubMed ID: 12536483
[TBL] [Abstract][Full Text] [Related]
11. FOXA1 represses the molecular phenotype of basal breast cancer cells.
Bernardo GM; Bebek G; Ginther CL; Sizemore ST; Lozada KL; Miedler JD; Anderson LA; Godwin AK; Abdul-Karim FW; Slamon DJ; Keri RA
Oncogene; 2013 Jan; 32(5):554-63. PubMed ID: 22391567
[TBL] [Abstract][Full Text] [Related]
12. Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings.
Hashmi AA; Bukhari U; Najam J; Dowlah T; Ali AH; Diwan MA; Anjali F; Sham S; Zia S; Irfan M
Cureus; 2023 Jun; 15(6):e40066. PubMed ID: 37425505
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.
Prado-Vázquez G; Gámez-Pozo A; Trilla-Fuertes L; Arevalillo JM; Zapater-Moros A; Ferrer-Gómez M; Díaz-Almirón M; López-Vacas R; Navarro H; Maín P; Feliú J; Zamora P; Espinosa E; Fresno Vara JÁ
Sci Rep; 2019 Feb; 9(1):1538. PubMed ID: 30733547
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.
Fonseca FP; Bingle L; Santos-Silva AR; Lopes MA; Coletta RD; de Andrade BA; Mariano FV; Kowalski LP; Rangel AL; Martins MD; Meurer L; Hunter KD; Speight PM; Vargas PA
J Oral Pathol Med; 2016 Oct; 45(9):672-681. PubMed ID: 26991799
[TBL] [Abstract][Full Text] [Related]
16. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
Noblejas-López MDM; Gandullo-Sánchez L; Galán-Moya EM; López-Rosa R; Tébar-García D; Nieto-Jiménez C; Gómez-Juárez M; Burgos M; Pandiella A; Ocaña A
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628286
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours.
Goh JJH; Goh CJH; Lim QW; Zhang S; Koh CG; Chiam KH
Sci Rep; 2022 Dec; 12(1):20902. PubMed ID: 36463288
[TBL] [Abstract][Full Text] [Related]
18. High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma.
Yan M; Yin X; Zhang L; Cui Y; Ma X
Mol Biol Rep; 2022 Apr; 49(4):2607-2618. PubMed ID: 35028857
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
20. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.
Su Y; Zheng Y; Zheng W; Gu K; Chen Z; Li G; Cai Q; Lu W; Shu XO
BMC Cancer; 2011 Jul; 11():292. PubMed ID: 21749714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
